Compound 48/80 Activates Mast Cell Phospholipase D via Heterotrimeric GTP-Binding Proteins

  1. Ahmed Chahdi,
  2. Paul F. Fraundorfer and
  3. Michael A. Beaven
  1. Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland

    Abstract

    Previous studies have indicated the presence of a cholera toxin-sensitive phospholipase D (PLD) in cultured RBL-2H3 mast cells that is synergistically activated via calcium, protein kinase C, and another unidentified signal. Here we identify a third potential signal for activation transduced by a pertussis toxin-sensitive trimeric GTP-binding protein, most likely via Gi2 or Gi3. Quercetin-treated RBL-2H3 cells in which expression of Gαi2 and Gαi3 is enhanced more than 7-fold respond to the Gi stimulant compound 48/80 with the activation of PLD, a transient activation of phospholipase C, and enhanced membrane GTPase activity. The activation of PLD was blocked in pertussis toxin-treated cells and, as with other stimulants of PLD, was enhanced in cholera toxin-treated cells. The PLD response to compound 48/80 was only partially inhibited by calcium deprivation and inhibition of protein kinase C to indicate a component of the response that was independent of calcium, protein kinase C, and, presumably, phospholipase C. Based on these and other data, we hypothesized that βγ-subunits, released from Gi2 or Gi3 by compound 48/80 or from Gs by cholera toxin, provide an additional signal for the activation of PLD. Consistent with this hypothesis, recombinant Gβ2γ2 subunits, but not Gαi-3 subunits, at concentrations of 50 to 300 nM markedly synergized PLD activation by compound 48/80 in permeabilized RBL-2H3 cells.

    Footnotes

    • Send reprint requests to: Dr. Michael A. Beaven, Room 8N109/Bldg. 10, National Institutes of Health, Bethesda, MD 20892-1760. E-mail:beaven{at}helix.nih.gov

    • Received for publication May 13, 1999.

    • Abbreviations:
      PLD
      phospholipase D
      PLC
      phospholipase C
      G protein
      trimeric GTP-binding protein
      GTPγS
      guanosine-5′-O-(3-thio)triphosphate
      CHAPS
      3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate
      PIPES
      piperazine-N,N′-bis(2-ethanesulfonic acid)
      ARF
      ADP-ribosylation factor
      mARF
      myristoylated ADP-ribosylation factor
      • Accepted September 17, 1999.
    « Previous | Next Article »Table of Contents